Development of a pharmaceutical apotransferrin product for iron binding therapy.

Development of a pharmaceutical apotransferrin product for iron binding therapy.

Item
http://www.wikidata.org/entity/Q31942658
Mutation of the Second Sialic Acid-Binding Site, Resulting in Reduced Neuraminidase Activity, Preceded the Emergence of H7N9 Influenza A Virus.Alpha2,3 and alpha2,6 N-linked sialic acids facilitate efficient binding and transduction by adeno-associated virus types 1 and 6Nanofiltration of plasma-derived biopharmaceutical products.Rust and corrosion in hematopoietic stem cell transplantation: the problem of iron and oxidative stress.Therapeutic potential of iron chelators in diseases associated with iron mismanagement.Detection and differentiation of human parvovirus variants by commercial quantitative real-time PCR tests.High-level production of animal-free recombinant transferrin from Saccharomyces cerevisiae.Effect of iron-chelator deferiprone on the in vitro growth of staphylococci.Mass spectrometric characterization of transferrins and their fragments derived by reduction of disulfide bonds.Effect of repeated apotransferrin administrations on serum iron parameters in patients undergoing myeloablative conditioning and allogeneic stem cell transplantation.Function and Therapeutic Development of ApotransferrinSubstrate Binding by the Second Sialic Acid-Binding Site of Influenza A Virus N1 Neuraminidase Contributes to Enzymatic Activity
P2860

Development of a pharmaceutical apotransferrin product for iron binding therapy.

Item
http://www.wikidata.org/entity/Q31942658
description
2001 nî lūn-bûn
@nan
2001 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի մարտին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
Development of a pharmaceutical apotransferrin product for iron binding therapy.
@ast
Development of a pharmaceutical apotransferrin product for iron binding therapy.
@en
type
label
Development of a pharmaceutical apotransferrin product for iron binding therapy.
@ast
Development of a pharmaceutical apotransferrin product for iron binding therapy.
@en
prefLabel
Development of a pharmaceutical apotransferrin product for iron binding therapy.
@ast
Development of a pharmaceutical apotransferrin product for iron binding therapy.
@en
P1433
P1476
P2093
P304
P31
P356
P433
P478
P577
P698
P356
P1433
P1476
Development of a pharmaceutical apotransferrin product for iron binding therapy.
@en
P2093
P304
P31
P356
P433
P478
P577
P698